Skip to content

Insider · CIK 0001259254

Mark W Kroll

director

Files at HAE (HAEMONETICS CORP). First filing Nov 12, 2025, latest Nov 12, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$99k bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
28Weak
HAEbuy
HAEMONETICS CORP
$99k
1,400 shares
+6%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 10, 2025HAE
HAEMONETICS CORP
POpen-market purchase
Common Stock
+1,400$70.56$99k24,757Nov 12, 2025
Jul 24, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+2,693--23,357Jul 25, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark W Kroll: insider trades and track record | InsiderTell